GRI Bio GRI Income Statement (2020-2026)

NASDAQ GRI
$1.67 -0.06 (-3.47%)
At close: Aug 20, 2026 · 4:00 PM EDT
Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
Operating items
Research & Development (Quarter)
1.20M0.21M2.00M1.27M0.06M0.06M0.06M0.12M0.88M1.19M1.05M0.93M0.88M1.12M0.91M1.64M1.88M1.77M1.63M0.36M
Selling, General & Administrative (Quarter)
1.11M1.04M1.10M1.36M0.13M0.12M1.61M0.87M5.05M1.25M0.98M0.96M1.38M1.00M1.05M1.41M1.02M1.60M1.03M1.64M
Operating Expenses (Quarter)
2.31M1.25M3.09M2.63M0.19M0.19M1.67M0.99M5.93M2.44M2.03M1.90M2.26M2.13M1.95M3.05M2.90M3.37M2.66M2.00M
Operating Income (Quarter)
-2.31M-1.25M-3.09M-2.63M-0.19M-0.19M-1.67M-0.99M-5.93M-2.44M-2.03M-1.90M-2.26M-2.13M-1.95M-3.05M-2.90M-3.37M-2.66M-2.00M
EBIT (Quarter)
-2.31M-1.25M-3.09M-2.63M-0.19M-0.19M-1.67M-0.99M-5.93M-2.44M-2.03M-1.90M-2.26M-2.13M-1.95M-3.05M-2.90M-3.37M-2.66M-2.00M
Non-operating items
Non Operating Investment Income (Quarter)
-0.00M0.00M
Interest & Investment Income (Quarter)
-0.00M-0.00M-0.00M0.00M
Other Non Operating Income (Quarter)
0.12M0.05M0.01M0.00M0.00M
Non Operating Income (Quarter)
-0.11M-0.17M-0.28M-1.16M-0.93M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Net income details
EBT (Quarter)
-2.31M-1.26M-10.11M-2.64M-0.19M-0.19M-5.16M-0.99M-5.93M-2.44M-16.55M-1.90M-2.26M-2.13M-18.64M-3.05M-2.90M-3.47M-22.61M-2.00M
Profit After Tax (Quarter)
-2.31M-1.26M-3.10M-0.30M-0.29M-0.35M-2.27M-2.15M-6.75M-2.14M-2.00M-1.89M-2.25M-2.12M-1.95M-3.05M-2.89M-3.36M-2.66M-2.00M
Income from Continuing Operations (Quarter)
-2.31M-1.26M-10.11M-2.64M-0.19M-0.19M-5.16M-0.99M-5.93M-2.44M-16.55M-1.90M-2.26M-2.13M-18.64M-3.05M-2.90M-3.47M-22.61M-2.00M
Consolidated Net Income (Quarter)
-2.31M-1.26M-10.11M-2.64M-0.19M-0.19M-5.16M-0.99M-5.93M-2.44M-16.55M-1.90M-2.26M-2.13M-18.64M-3.05M-2.90M-3.47M-22.61M-2.00M
Income towards Parent Company (Quarter)
-2.31M-1.26M-10.11M-2.64M-0.19M-0.19M-5.16M-0.99M-5.93M-2.44M-16.55M-1.90M-2.26M-2.13M-18.64M-3.05M-2.90M-3.47M-22.61M-2.00M
Net Income towards Common Stockholders (Quarter)
-2.31M-1.26M-10.11M-2.64M-0.19M-0.19M-5.16M-0.99M-5.93M-2.44M-16.55M-1.90M-2.26M-2.13M-18.64M-3.05M-2.90M-3.47M-22.61M-2.00M
Additional items
EPS (Basic) (Quarter)
-0.46M-0.25M-2.02M-0.53M-0.03M-0.02M-0.65M-0.10M-0.11M-0.03M-0.22M-0.00M-0.00M-320.83-0.00M-162.60-36.79-37.08-230.38-1.61
EPS (Diluted) (Quarter)
-0.46M-0.25M-2.02M-0.53M-0.03M-0.02M-0.65M-0.10M-0.11M-0.03M-0.22M-0.00M-0.00M-320.83-0.00M-162.60-36.79-37.08-230.38-1.61
Shares Outstanding (Quarter)
5.005.005.005.007.009.008.0010.0056.0095.0075.00667.00961.000.01M0.01M0.02M0.08M0.09M0.10M1.24M
Shares Outstanding (Diluted) (Quarter)
5.005.005.005.007.009.008.0010.0056.0095.0075.00667.00961.000.01M0.01M0.02M0.08M0.09M0.10M1.24M
Shares Outstanding (Entity) (Quarter)
5.005.005.005.008.0010.008.0010.0056.0095.0075.00667.00961.000.01M0.01M0.02M0.09M0.09M0.10M1.24M
EBITDA (Quarter)
-2.31M-1.25M-3.09M-2.63M-0.19M-0.19M-1.67M-0.99M-5.93M-2.44M-2.03M-1.90M-2.26M-2.13M-1.95M-3.05M-2.90M-3.37M-2.66M-2.00M
Interest Expenses (Quarter)
0.00M7.01M0.01M0.00M0.00M3.50M14.52M16.68M0.11M19.95M